A focus on the association of Apol1 with kidney disease in children

被引：12

作者：

Ekulu, Pepe M. ^{[1
,2
]}

Nkoy, Agathe B. ^{[2
]}

Adebayo, Oyindamola C. ^{[1
]}

Kazadi, Orly K. ^{[2
]}

Aloni, Michel N. ^{[2
]}

Arcolino, Fanny O. ^{[1
]}

Ngiyulu, Rene M. ^{[2
]}

Gini, Jean-Lambert E. ^{[2
]}

Lepira, Francois B. ^{[3
]}

van den Heuvel, Lamberthus P. ^{[1
,4
]}

Levtchenko, Elena N. ^{[5
,6
]}

机构：

[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium

[2] Univ Kinshasa, Div Nephrol, Dept Pediat, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO

[3] Univ Kinshasa, Div Nephrol, Dept Internal Med, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO

[4] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands

[5] Katholieke Univ Leuven, Dept Pediat Nephrol, Univ Hosp Leuven, Leuven, Belgium

[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Univ Hosp Leuven, Leuven, Belgium

来源：

PEDIATRIC NEPHROLOGY | 2021年 / 36卷 / 04期

关键词：

APOL1; Chronic kidney disease; Children; Genetics; Sickle cell disease; HIV-associated nephropathy; STAGE RENAL-DISEASE; AFRICAN-AMERICAN CHILDREN; RISK VARIANTS; APOLIPOPROTEIN L1; NEPHROPATHY; GENE; GENOTYPE; OUTCOMES; ALLELES; ADULTS;

D O I：

10.1007/s00467-020-04553-z

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.

引用

页码：777 / 788

页数：12

共 50 条

[31] APOL1 at 10 years: progress and next steps
Freedman, Barry, I
Kopp, Jeffrey B.
Sampson, Matthew G.
Susztak, Katalin
KIDNEY INTERNATIONAL, 2021, 99 (06) : 1296 - 1302
[32] APOL1 Kidney Risk Variants and Proteomics
Chen, Teresa K.
Surapaneni, Aditya L.
Arking, Dan E.
Ballantyne, Christie M.
Boerwinkle, Eric
Chen, Jingsha
Coresh, Josef
Koettgen, Anna
Susztak, Katalin
Tin, Adrienne
Yu, Bing
Grams, Morgan E.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
[33] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
Egbuna, Ogo
Zimmerman, Brandon
Manos, George
Fortier, Anne
Chirieac, Madalina C.
Dakin, Leslie A.
Friedman, David J.
Bramham, Kate
Campbell, Kirk
Knebelmann, Bertrand
Barisoni, Laura
Falk, Ronald J.
Gipson, Debbie S.
Lipkowitz, Michael S.
Ojo, Akinlolu
Bunnage, Mark E.
Pollak, Martin R.
Altshuler, David
Chertow, Glenn M.
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11) : 969 - 979
[34] APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans
Gbadegesin, Rasheed A.
Ulasi, Ifeoma
Ajayi, Samuel
Raji, Yemi
Olanrewaju, Timothy
Osafo, Charlotte
Ademola, Adebowale D.
Asinobi, Adanze
Winkler, Cheryl A.
Burke, David
Arogundade, Fatiu
Ekem, Ivy
Plange-Rhule, Jacob
Mamven, Manmak
Matekole, Michael
Amodu, Olukemi
Cooper, Richard
Antwi, Sampson
Adeyemo, Adebowale A.
Ilori, Titilayo O.
Adabayeri, Victoria
Nyarko, Alexander
Ghansah, Anita
Amira, Toyin
Solarin, Adaobi
Awobusuyi, Olugbenga
Kimmel, Paul L.
Brosius, Frank Chip
Makusidi, Muhammad
Odenigbo, Uzoma
Kretzler, Matthias
Hodgin, Jeffrey B.
Pollak, Martin R.
Boima, Vincent
Freedman, Barry I.
Palmer, Nicholette D.
Collins, Bernard
Phadnis, Milind
Smith, Jill
Agwai, Celia I.
Okoye, Ogochukwu
Abdu, Aliyu
Wilson, Jillian
Williams, Winfred
Salako, Babatunde L.
Parekh, Rulan S.
Tayo, Bamidele
Adu, Dwomoa
Ojo, Akinlolu
NEW ENGLAND JOURNAL OF MEDICINE, 2024,
[35] APOL1 variants and kidney disease in people of recent African ancestry
Genovese, Giulio
Friedman, David J.
Pollak, Martin R.
NATURE REVIEWS NEPHROLOGY, 2013, 9 (04) : 240 - 244
[36] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, Afshin
Kao, W. H. Linda
Xie, Dawei
Astor, Brad C.
Li, Man
Hsu, Chi-yuan
Feldman, Harold I.
Parekh, Rulan S.
Kusek, John W.
Greene, Tom H.
Fink, Jeffrey C.
Anderson, Amanda H.
Choi, Michael J.
Wright, Jackson T., Jr.
Lash, James P.
Freedman, Barry I.
Ojo, Akinlolu
Winkler, Cheryl A.
Raj, Dominic S.
Kopp, Jeffrey B.
He, Jiang
Jensvold, Nancy G.
Tao, Kaixiang
Lipkowitz, Michael S.
Appel, Lawrence J.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) : 2183 - 2196
[37] APOL1 nephropathy: from gene to mechanisms of kidney injury
Kruzel-Davila, Etty
Wasser, Walter G.
Aviram, Sharon
Skorecki, Karl
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (03) : 349 - 358
[38] APOL1 and Proteinuria in the AASK Unraveling the Pathobiology of APOL1
O'Toole, John F.
Bruggeman, Leslie A.
Sedor, John R.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (11): : 1723 - 1725
[39] Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
McCarthy, Gizelle M.
Blasio, Angelo
Donovan, Olivia G.
Schaller, Lena B.
Bock-Hughes, Althea
Magraner, Jose M.
Suh, Jung Hee
Tattersfield, Calum F.
Stillman, Isaac E.
Shah, Shrijal S.
Zsengeller, Zsuzsanna K.
Subramanian, Balajikarthick
Friedman, David J.
Pollak, Martin R.
DISEASE MODELS & MECHANISMS, 2021, 14 (08)
[40] APOL1 Genetic Testing in Living Kidney Transplant Donors
Mohan, Sumit
Iltis, Ana S.
Sawinski, Deirdre
DuBois, James M.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 74 (04) : 538 - 543

← 1 2 3 4 5 →